Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine
- PMID:6734729
- DOI: 10.1016/0014-2999(84)90247-4
Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine
Abstract
Adinazolam , a triazolobenzodiazepine , has been reported to be an effective antidepressant treatment in major depression. In the present study, a 14-day (but not a five-day) treatment with adinazolam enhanced the responsiveness of rat hippocampal pyramidal neurons to microiontophoretically applied 5-HT but not to NE. A 14-day treatment with diazepam failed to induce sensitization to either 5-HT or NE. Acute intravenous administration of adinazolam did not modify dorsal raphe 5-HT neuron firing rate. It is proposed that the antidepressant activity of adinazolam might be mediated by a heightened 5-HT neurotransmission.
Similar articles
- Adinazolam affects biogenic amine release in hippocampal CA1 neuronal circuitry.Broderick PA.Broderick PA.Brain Res Bull. 1991 Nov;27(5):689-92. doi: 10.1016/0361-9230(91)90046-m.Brain Res Bull. 1991.PMID:1756387
- Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat.Blier P, de Montigny C, Tardif D.Blier P, et al.Psychopharmacology (Berl). 1984;84(2):242-9. doi: 10.1007/BF00427453.Psychopharmacology (Berl). 1984.PMID:6438684
- Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine.Lahti RA, Sethy VH, Barsuhn C, Hester JB.Lahti RA, et al.Neuropharmacology. 1983 Nov;22(11):1277-82. doi: 10.1016/0028-3908(83)90200-9.Neuropharmacology. 1983.PMID:6320036
- Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.Blier P, de Montigny C, Chaput Y.Blier P, et al.J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):24S-35S.J Clin Psychopharmacol. 1987.PMID:3323264Review.
- Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment.de Montigny C, Blier P, Chaput Y.de Montigny C, et al.Neuropharmacology. 1984 Dec;23(12B):1511-20. doi: 10.1016/0028-3908(84)90095-9.Neuropharmacology. 1984.PMID:6396527Review.No abstract available.
Cited by
- Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal.Broderick PA, Hope O, Jeannot P.Broderick PA, et al.Prog Neuropsychopharmacol Biol Psychiatry. 1998 Feb;22(2):353-86. doi: 10.1016/s0278-5846(98)00010-4.Prog Neuropsychopharmacol Biol Psychiatry. 1998.PMID:9608607Free PMC article.
- Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K.Amsterdam JD, et al.Psychopharmacology (Berl). 1986;88(4):484-8. doi: 10.1007/BF00178511.Psychopharmacology (Berl). 1986.PMID:3085137Clinical Trial.
- Recent findings and advancements in the detection of designer benzodiazepines: a brief review.Wu D, Fu L.Wu D, et al.Arh Hig Rada Toksikol. 2023 Dec 29;74(4):224-231. doi: 10.2478/aiht-2023-74-3771. eCollection 2022.Arh Hig Rada Toksikol. 2023.PMID:38146763Free PMC article.Review.
- N-desmethyladinazolam pharmacokinetics and behavioral effects following administration of 10-50 mg oral doses in healthy volunteers.Fleishaker JC, Smith TC, Friedman H, Phillips JP.Fleishaker JC, et al.Psychopharmacology (Berl). 1991;105(2):181-5. doi: 10.1007/BF02244306.Psychopharmacology (Berl). 1991.PMID:1796125Clinical Trial.
- Serotonergic function during lithium augmentation of refractory depression.McCance-Katz E, Price LH, Charney DS, Heninger GR.McCance-Katz E, et al.Psychopharmacology (Berl). 1992;108(1-2):93-7. doi: 10.1007/BF02245291.Psychopharmacology (Berl). 1992.PMID:1410150
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical